Although urinary tract infections (UTIs) are typically minor—albeit painful—health issues for most people, they can pose serious risks for older adults, particularly those with Alzheimer's disease and other forms of dementia. ...
Feb 24, 2026
0
1
So-called "yo-yo dieting" confers long-term health benefits, according to a new study by Ben-Gurion University of the Negev researchers. "Yo-yo dieting" is a pattern in which individuals lose weight through lifestyle interventions ...
Feb 24, 2026
0
0
Individuals living with type 2 diabetes (T2D) had a significantly lower risk of poor cardiovascular health when they used a GLP-1 receptor agonist (GLP-1 RA) in combination with adhering to healthy lifestyle habits, according ...
Feb 25, 2026
0
0
Ketamine is a powerful anesthetic used for surgery and acute pain management. But in recent years, it has also gained a reputation as a potential treatment for certain mental health conditions like stress and anxiety. In ...
A new, daily oral tablet that combines two current HIV treatment medications, bictegravir and lenacapavir (BIC/LEN), could effectively replace more complicated HIV treatment regimens used by people living with HIV who are ...
Feb 25, 2026
0
0
Ivermectin was originally celebrated as a revolutionary treatment for parasitic disease in humans and animals. It has since evolved into a focal point of misinformation and heated debate.
Mar 1, 2026
0
0
EPFL researchers have developed preclinical models for invasive lobular carcinoma and trialed a new drug. It slows tumor growth effectively by targeting specific features of the disease and opening the door to future clinical ...
Feb 26, 2026
0
0
An autoimmune disorder that affects the thyroid gland, called autoimmune hypothyroidism (AIHT), is the most common autoimmune disease, yet it remains largely understudied. New research from scientists at Broad Institute, ...
Feb 26, 2026
0
0
A novel GLP-1 receptor agonist (RA) pill called orforglipron leads to a larger reduction in blood sugar levels after a year than the current available oral GLP-1 RA (semaglutide), finds a phase 3 randomized controlled trial ...
Feb 26, 2026
0
0
A Dartmouth study challenges the conventional view that the amygdala—the two-sided structure deep in the brain involved in emotion, learning, and decision making—is simply the brain's primitive "fear center," reflexively ...
Feb 24, 2026
0
1
